- call +1-201-465-4211
- email sales@mrinsights.biz
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
Scope of the Report:
This report focuses on the Oxaliplatin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Teva and Jiangsu Hengrui Medicine.
The technological level of Oxaliplatin in China has a big gap compared with the international advanced level. Outstanding performance in product application performance is not outstanding, function is not strong, supporting enough, clean low level, product updates slow, long development cycle. There is little Oxaliplatin performance in China at or near the international advanced level.
The worldwide market for Oxaliplatin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Mannitol
Glucose Solution
Lactose Solution
Other
Market Segment by Applications, can be divided into
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
There are 15 Chapters to deeply display the global Oxaliplatin market.
Chapter 1, to describe Oxaliplatin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oxaliplatin, with sales, revenue, and price of Oxaliplatin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oxaliplatin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oxaliplatin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oxaliplatin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oxaliplatin Introduction
1.2 Market Analysis by Type
1.2.1 Mannitol
1.2.2 Glucose Solution
1.2.3 Lactose Solution
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Colorectal Cancer
1.3.2 Stomach Cancer
1.3.3 Ovarian Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Oxaliplatin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi-Aventis Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Yakult honsha
2.2.1 Business Overview
2.2.2 Oxaliplatin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Yakult honsha Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dr Reddy's laboratories
2.3.1 Business Overview
2.3.2 Oxaliplatin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dr Reddy's laboratories Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Oxaliplatin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva
2.5.1 Business Overview
2.5.2 Oxaliplatin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Fresenius Kabi
2.6.1 Business Overview
2.6.2 Oxaliplatin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fresenius Kabi Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hospira
2.7.1 Business Overview
2.7.2 Oxaliplatin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hospira Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mylan
2.8.1 Business Overview
2.8.2 Oxaliplatin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Jiangsu Hengrui Medicine
2.9.1 Business Overview
2.9.2 Oxaliplatin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Nanjing Pharmaceutical Factory
2.10.1 Business Overview
2.10.2 Oxaliplatin Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Jiangsu Aosaikang Pharmaceutical
2.11.1 Business Overview
2.11.2 Oxaliplatin Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Qilu Pharmaceutical
2.12.1 Business Overview
2.12.2 Oxaliplatin Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Hisun Pharmaceutical
2.13.1 Business Overview
2.13.2 Oxaliplatin Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Hisun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Lunan Pharmaceutical
2.14.1 Business Overview
2.14.2 Oxaliplatin Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Lunan Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Luoxin
2.15.1 Business Overview
2.15.2 Oxaliplatin Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Luoxin Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Halfsky Pharmacy
2.16.1 Business Overview
2.16.2 Oxaliplatin Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Halfsky Pharmacy Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 YRPG
2.17.1 Business Overview
2.17.2 Oxaliplatin Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 YRPG Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Hainan Jinrui Pharmaceutical
2.18.1 Business Overview
2.18.2 Oxaliplatin Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Jari Pharmaceutical
2.19.1 Business Overview
2.19.2 Oxaliplatin Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Jari Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Chiatai Tianqing
2.20.1 Business Overview
2.20.2 Oxaliplatin Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Chiatai Tianqing Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oxaliplatin Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oxaliplatin Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oxaliplatin Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oxaliplatin Manufacturer Market Share in 2017
3.3.2 Top 6 Oxaliplatin Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oxaliplatin Market Analysis by Regions
4.1 Global Oxaliplatin Sales, Revenue and Market Share by Regions
4.1.1 Global Oxaliplatin Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oxaliplatin Revenue and Market Share by Regions (2013-2018)
4.2 North America Oxaliplatin Sales and Growth Rate (2013-2018)
4.3 Europe Oxaliplatin Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oxaliplatin Sales and Growth Rate (2013-2018)
4.5 South America Oxaliplatin Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oxaliplatin Sales and Growth Rate (2013-2018)
5 North America Oxaliplatin by Countries
5.1 North America Oxaliplatin Sales, Revenue and Market Share by Countries
5.1.1 North America Oxaliplatin Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oxaliplatin Revenue and Market Share by Countries (2013-2018)
5.2 United States Oxaliplatin Sales and Growth Rate (2013-2018)
5.3 Canada Oxaliplatin Sales and Growth Rate (2013-2018)
5.4 Mexico Oxaliplatin Sales and Growth Rate (2013-2018)
6 Europe Oxaliplatin by Countries
6.1 Europe Oxaliplatin Sales, Revenue and Market Share by Countries
6.1.1 Europe Oxaliplatin Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oxaliplatin Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oxaliplatin Sales and Growth Rate (2013-2018)
6.3 UK Oxaliplatin Sales and Growth Rate (2013-2018)
6.4 France Oxaliplatin Sales and Growth Rate (2013-2018)
6.5 Russia Oxaliplatin Sales and Growth Rate (2013-2018)
6.6 Italy Oxaliplatin Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oxaliplatin by Countries
7.1 Asia-Pacific Oxaliplatin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oxaliplatin Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oxaliplatin Revenue and Market Share by Countries (2013-2018)
7.2 China Oxaliplatin Sales and Growth Rate (2013-2018)
7.3 Japan Oxaliplatin Sales and Growth Rate (2013-2018)
7.4 Korea Oxaliplatin Sales and Growth Rate (2013-2018)
7.5 India Oxaliplatin Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oxaliplatin Sales and Growth Rate (2013-2018)
8 South America Oxaliplatin by Countries
8.1 South America Oxaliplatin Sales, Revenue and Market Share by Countries
8.1.1 South America Oxaliplatin Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oxaliplatin Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oxaliplatin Sales and Growth Rate (2013-2018)
8.3 Argentina Oxaliplatin Sales and Growth Rate (2013-2018)
8.4 Colombia Oxaliplatin Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oxaliplatin by Countries
9.1 Middle East and Africa Oxaliplatin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oxaliplatin Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oxaliplatin Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oxaliplatin Sales and Growth Rate (2013-2018)
9.3 UAE Oxaliplatin Sales and Growth Rate (2013-2018)
9.4 Egypt Oxaliplatin Sales and Growth Rate (2013-2018)
9.5 Nigeria Oxaliplatin Sales and Growth Rate (2013-2018)
9.6 South Africa Oxaliplatin Sales and Growth Rate (2013-2018)
10 Global Oxaliplatin Market Segment by Type
10.1 Global Oxaliplatin Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oxaliplatin Sales and Market Share by Type (2013-2018)
10.1.2 Global Oxaliplatin Revenue and Market Share by Type (2013-2018)
10.2 Mannitol Sales Growth and Price
10.2.1 Global Mannitol Sales Growth (2013-2018)
10.2.2 Global Mannitol Price (2013-2018)
10.3 Glucose Solution Sales Growth and Price
10.3.1 Global Glucose Solution Sales Growth (2013-2018)
10.3.2 Global Glucose Solution Price (2013-2018)
10.4 Lactose Solution Sales Growth and Price
10.4.1 Global Lactose Solution Sales Growth (2013-2018)
10.4.2 Global Lactose Solution Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Oxaliplatin Market Segment by Application
11.1 Global Oxaliplatin Sales Market Share by Application (2013-2018)
11.2 Colorectal Cancer Sales Growth (2013-2018)
11.3 Stomach Cancer Sales Growth (2013-2018)
11.4 Ovarian Cancer Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Oxaliplatin Market Forecast (2018-2023)
12.1 Global Oxaliplatin Sales, Revenue and Growth Rate (2018-2023)
12.2 Oxaliplatin Market Forecast by Regions (2018-2023)
12.2.1 North America Oxaliplatin Market Forecast (2018-2023)
12.2.2 Europe Oxaliplatin Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oxaliplatin Market Forecast (2018-2023)
12.2.4 South America Oxaliplatin Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oxaliplatin Market Forecast (2018-2023)
12.3 Oxaliplatin Market Forecast by Type (2018-2023)
12.3.1 Global Oxaliplatin Sales Forecast by Type (2018-2023)
12.3.2 Global Oxaliplatin Market Share Forecast by Type (2018-2023)
12.4 Oxaliplatin Market Forecast by Application (2018-2023)
12.4.1 Global Oxaliplatin Sales Forecast by Application (2018-2023)
12.4.2 Global Oxaliplatin Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oxaliplatin Picture
Table Product Specifications of Oxaliplatin
Figure Global Sales Market Share of Oxaliplatin by Types in 2017
Table Oxaliplatin Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
